Methods and Assays to Assess Cardiac Risk and Ischemia
United States Patent Application 20090233312
Inventors: Winton Gibbons, Thomas Holzman, Phillip Lefebvre, Gregory Shipp
The invention provides methods and apparatus to assess cardiac risk and ischemia by detecting or analyzing cardiac troponin levels. Also provided are methods to detect low levels of cardiac troponin in physiological fluid samples.
United States Patent Application 20100144055
Inventors: Thomas Holzman, Winton Gibbons
The disclosure provides methods of detecting autoantibodies (AAs) in biological samples. The methods use capture probes that can bind to an disease-associated antigen/AA complex and a detection probe that can bind to the AAs. The presence, absence, and/or amount of the complex may be measured, wherein the presence of the complex may be diagnostic or prognostic of a disease or medical condition. The disclosure also provides methods of simultaneously detecting AAs and antigens in biological samples. The presence, absence, and/or amount of AAs and antigens may be measured, wherein the amount of antigen present and/or the amount of autoantibody present may be diagnostic or prognostic of a particular disease or medical condition.
Detection of Complexes of Tau and Amyloid
United Kingdom Patent Application PCT/US2010/025231
Inventors: Winton Gibbons, Thomas Holzman, Lei Chang, Claude Lerner
The present technology relates generally to diagnostic and prognostic methods for neurological diseases such as mild cognitive impairment (MCI) and Alzheimer’s disease. In particular, the present disclosure relates to methods for detecting complexes of Tau, Tau variants, including phosphorylated variants, and amyloid containing molecules, as well as autoantibodies to those complexes or components of those complexes, in physiological fluid samples, which complexes are markers for neurological diseases such as mild cognitive impairment.
Assays for Clinical Assessments of Rheumatoid Arthritis
United States Patent Application 20110014632
Inventors: Winton Gibbons, Thomas Holzman, Claude Lerner
The disclosure provides methods of detecting autoantibodies present in the serum of subjects suffering from rheumatoid arthritis. The methods use capture probes and detection probes that can bind to the antifilaggrin autoantibodies or other epitope related autoantibodies. The presence, absence, and/or amount of the autoantibody complex may be detected, wherein the presence of the complex may indicate a positive diagnosis of rheumatoid arthritis.